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impedance Testing in esophageal 
Atresia Patients
Maheen Hassan and Hayat Mousa*
Department of Pediatric Gastroenterology, University of California San Diego, San Diego, CA, USA
Esophageal atresia patients are predisposed to gastroesophageal reflux as a result of the 
altered esophageal anatomy and motility. These patients experience significant morbidity 
from gastroesophageal reflux. As a result, an effective way to diagnose and monitor for 
reflux is crucial. pH-metry is able to quantify acid burden, ensure that acid suppression 
is adequate during long-term follow-up, and correlate acid reflux to symptoms. pH with 
impedance is additionally able to detect non-acid reflux as well as volume clearance, 
both of which also correlate with patient symptoms. It is also able to correlate extra- 
gastrointestinal symptoms to reflux, which may help guide treatment. If complications 
associated with uncontrolled reflux are identified, aggressive reflux management is nec-
essary, oftentimes requiring surgical intervention.
Keywords: esophageal atresia, gastroesophageal reflux, esophageal pH, impedance, tracheoesophageal fistula, 
multichannel intraluminal impedance, pH impedance
Gastroesophageal reflux disease (GERD) is the most common long-term complication of esophageal 
atresia (EA)–tracheoesophageal fistula (TEF), affecting between 22 and 75% of pediatric patients 
(1–3). The increased risk of GERD in this group is due to both intrinsic dysmotility and structural 
factors. Primary dysmotility is a result of abnormal development of esophageal smooth muscle, with 
histopathologic features including distortion of smooth muscle, fibrous tissue in between smooth 
muscle layers (4), and tracheobronchial remnants present in the esophagus (5). In addition, there is 
abnormal congenital neural innervation of the esophagus, with a hypoplastic Auerbach plexus (6) 
and decreased interstitial cells of Cajal (7). Structurally, after surgical repair, most EA patients lose 
some function of the anti-reflux barrier. While anatomic changes vary from patient to patient, those 
most affected are patients with long gap EA. With gastric pull-up surgery, the lower esophageal 
sphincter (LES) is displaced proximal to the hiatus formed by the crural diaphragm, and without 
the overlap between the two, the anti-reflux barrier becomes incompetent (8). Gastric content can 
get trapped in the sac created between the LES proximally and the crural diaphragm distally, and 
can reflux up during swallow-induced LES relaxation. Surgical mobilization of the lower esophagus 
also weakens the phrenoesophageal ligament, and decreases the angle of His, further affecting the 
anti-reflux barrier (9).
COMPLiCATiOn RiSKS SeCOnDARY TO GASTROeSOPHAGeAL 
ReFLUX
Given how common reflux is in EA patients and the high-risk of complications associated with GERD, 
it is imperative to diagnose and manage GERD appropriately in this population. Complications 
include dysphagia, esophagitis, Barrett’s esophagus, stricture formation, silent aspiration, and fail-
ure to thrive (Table 1). GERD is a frequently reported symptom in children and adolescence, with 
symptoms of GERD being reported in 22–58% of these patients (2, 3, 10, 11). As the majority of 
reflux experienced in these patients is acidic in nature, chronic acid exposure leads to esophagitis, 
TAbLe 2 | benefits and limitations of pH-only versus pH-impedance 
testing (23, 25, 28, 29).
benefits Limitations
pH-only •	 Quantifies frequency 
and duration of acid 
exposure
•	 Measures chemical 
clearance
•	 Able to correlate acid 
reflux to symptoms
•	 Readily available
•	 Easier to interpret than 
pH-impedance
•	 Unable to detect non-acid and 
weakly acid reflux
•	 Can overestimate acid exposure 
by picking up “pH-only” episodes
•	 Limited utility in patients on acid 
suppression, continuous feeds, 
or frequent feeding schedule
pH-impedance •	 Quantifies acid and 
non-acid reflux
•	 Detects liquid, gas and 
mixed refluxate
•	 Measures volume and 
chemical clearance
•	 Quantifies the height 
of refluxate
•	 Analysis is time consuming
•	 Low baseline impedance in 
esophageal atresia patients 
makes it difficult for automated 
analysis to detect reflux events, 
and must be manually reviewed
•	 Limited availability in certain 
medical centers and practices
TAbLe 1 | Complications of gastroesophageal reflux experienced by 
esophageal atresia patients (10, 11, 16–18).
Percentage
esophageal
Dysphagia 40–72
Esophagitis 25–53
Barrett’s esophagus 1–11
Esophageal stricture 18–50
Feeding difficulty 6–52
extraesophageal
Cough 39–80
Chronic lung disease 11
Worsening airway reactivity 13–35
Recurrent lower respiratory tract infection 13–60
Brief responsive unexplained events Up to 53
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increased risk of Barrett’s esophagus, and increased risk of recur-
rent anastomotic strictures (12–15).
While strictures can contribute to symptoms of dysphagia 
and feeding difficulties, they can also atypically present with 
pulmonary symptoms such as cough, chest pain, and hoarse-
ness (16). Brief resolved unexplained events (BRUE), formerly 
known as apparent life-threatening events, are thought to result 
from either aspiration, with reflux contents from the proximal 
esophagus entering the larynx, or from GER in the lower esopha-
gus stimulating respiratory symptoms (17). Further aerodi gestive 
complications resulting from GER include chronic aspira tion 
pneumonia, chronic lung disease with bronchiectasis and 
increased oxygen requirement, worsening of tracheomalacia and 
airway reactivity, and persistent atelectasis (13). Supporting the 
association between GERD and pulmonary complications is a 
study that demonstrated increased risk of chest infections in EA 
patients with early strictures compared to those without (19). 
Aspiration and respiratory problems can contribute to feeding 
difficulties in EA.
DiAGnOSTiC MeTHODS
Diagnosing Gastroesophageal Reflux by 
Quantifying Acid exposure
The utility of diagnosing GERD accurately and tailoring treatment 
accordingly is necessary to prevent the complications mentioned 
above. These patients are in a high-risk category given they have 
increased GER and almost universally have esophageal dysmotil-
ity (20, 21), which can impair reflux clearance. pH probe testing, 
pH-impedance testing, and wireless pH testing are currently 
the best objective measures for quantifying esophageal reflux 
(12), with each modality having its own benefits and limitations 
(Table 2). Twenty-four hours esophageal pH monitoring meas-
ures the frequency and duration of esophageal acid reflux, thereby 
quantifying esophageal acid burden. A drop in intraesophageal 
pH <4 for more than 5  s is considered acidic exposure (22). 
The reflux index (RI) is the percentage of time during the entire 
recording time with pH <4, with RI >7% considered abnormal, 
an RI <3% considered normal, and an RI between 3 and 7% 
indeterminate (22). While the sensitivity of abnormal esophageal 
pH in predicting erosive esophagitis in adults and children is 
high, ranging from 83 to 100% (23, 24), there are limitations to 
standard pH monitoring. It is a poor detector of weakly acidic 
(pH 4–7) reflux (25) and can also overestimate acid exposure 
by picking up “pH-only” episodes, in which there is no detected 
retrograde liquid refluxate (26). In infants and children, weakly 
acidic GER is more prevalent than in adults (26, 27), which can 
explain why symptoms are not always detected by esophageal pH 
monitoring (23). This elucidates the limitation in depending on 
only pH monitoring to diagnose reflux.
Utilizing Multichannel intraluminal 
impedance (Mii) in the Diagnosis  
of Gastroesophageal Reflux
Multichannel Intraluminal Impedance is an alternative diagnostic 
tool that utilizes change in impedance to measure the anterograde 
and retrograde movement of fluid, solids, and air in the esopha-
gus. Dual pH-multichannel intraluminal impedance (pH-MII) is 
able to detect both acid and non-acid GER, detect anterograde 
versus retrograde flow thereby distinguishing between swallows 
and GER, determine the height of refluxate, and differentiate 
between liquid, gas, or mixed refluxate (28, 30). MII also provides 
information about bolus transit, duration of bolus presence, time 
of bolus clearance, and time of acid clearance.
Though initially used as a research tool, pH-MII has been 
shown to be very useful in assessing reflux and clearance. The 
definitions listed below have been established based on several 
studies (26, 31):
•	 Liquid reflux: drop in impedance to ≤50% of the baseline value, 
with subsequent recovery, in two or more of the distal-most 
channels.
•	 Acid reflux: liquid reflux (using the aforementioned definition) 
in which the pH decreases and remains <4 for ≥5 s.
•	 Non-acid reflux: liquid reflux (using the aforementioned defi-
nition) in which the pH increases, is unchanged, or decreases 
by at least 1 pH unit while maintaining pH ≥4.
TAbLe 3 | normal values for reflux on pH-multichannel intraluminal impedance per 24 h in infants and children.
infants Children
Median (iQR) 95th % Median (iQR) 95th %
Index of acid regurgitation (%) 0.6 (0.3–0.9) 1.4 0.4 (0.2–0.8) 1.3
Number of acid regurgitation episodes in 24 h 20 (11–26) 48 14 (11–15) 55
Index of non-acid regurgitation (%) 0.7 (0.5–1.2) 2.5 0.1 (0–0.3) 1
Number of non-acid regurgitation episodes in 24 h 32 (16–45) 67 6 (3–11) 34
Index of GER episodes (%) 1.4 (0.9–1.2) 2.9 0.6 (0.3–1.2) 2.4
Number of GER episodes in 24 h 54 (33–69) 93 21 (11–41) 71
Mean GER bolus clearance time (s) 13 (11–16) 20 15 (12–19) 32
Adapted from Mousa et al. (32).
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•	 Gas reflux: simultaneous and rapid increases in impedance 
(>3,000 Ω) in two or more of the distal-most channels.
•	 Proximal reflux/“high reflux”: the refluxate reaches either/or 
both of the most proximal channels.
•	 Distal reflux: the refluxate is confined to the two most distal 
impedance channels.
•	 Bolus clearance time (BCT): time for bolus clearance from the 
esophagus.
•	 Acid clearance time (ACT): time for acid clearance from the 
esophagus.
Reference values for reflux parameters in infants and children 
on pH-MII over a 24 h period were previously published by a mul-
ticenter study (Table 3) (32). Patients were selected based on having 
no evidence of acid reflux or symptoms associated with regurgita-
tion, off anti-reflux medications at the time of the procedure, and 
no fundoplication. Based on the study findings, the following 
would be considered abnormal over a 24 h period, as it is above the 
95th percentile in this selected group of infants and children: >48 
acid reflux episodes or more than 67 non-acid reflux episodes in an 
infant; >55 acid reflux episodes or >34 non-acid reflux episode in a 
child; >93 total GER events in an infant and >71 total GER events 
in a child. A limitation in this study, as well as all studies done in 
children, is in the ethics of performing pH-MII in asymptomatic 
children. As all patients were symptomatic, true normal values can-
not be established. However, by setting strict selection criteria, it is 
likely that the patients selected have physiologic GER and can be 
used as a reference. Reflux parameters have also been described by 
a prior large-scale study of 700 children (33). Patients with normal 
RI had a mean of 39 ± 31 reflux episodes, compared to patients 
with pathological RI that had a mean of 58 ± 43 reflux episodes. 
The children selected were all symptomatic, with 21% having 
documented acid reflux. In this study, reflux was not differentiated 
into non-acid and acid reflux. A study to establish normal reflux 
parameters was additionally done in preterm infants, who were 
otherwise healthy (34). This study was limited due to all patients 
being on tube feedings, which can affect the number of reflux 
episodes, as the tube stents open the LES.
pH-Mii in Determining esophageal 
Clearance
pH-multichannel intraluminal impedance is useful in calculat-
ing esophageal clearance. Volume clearance involves primary 
and secondary peristalsis, and is followed by chemical clearance 
that neutralizes acid. The efficiency of volume clearance of a 
reflux episode is generally assessed using the most distal imped-
ance channel. The presence of reflux is identified by the imped-
ance waveform dropping to 50% of the baseline. The bolus is 
cleared from the distal esophagus when the impedance wave-
form again reaches 50% of impedance baseline (35). Reference 
values have been published, with the upper 95th percentile 
of bolus clearance being 20  s in infants and 32  s in children 
(Table 3).
While volume clearance is known to be accomplished by 
esophageal peristalsis, chemical clearance is known to be accom-
plished primarily by bicarbonate-rich saliva that neutralizes 
acid and washes the esophageal walls of gastric and duodenal 
debris (36). Chemical clearance is defined as the duration of 
esophageal acidification immediately followed the end of volume 
clearance (37). It begins the moment the impedance waveform 
in the distal-most channel returns to 50% of baseline and 
ends when the pH waveform reaches pH 4. Physiologic norms 
were determined for infants up to 1 year of age, and children 
between ages 1 and 18 years (38): the upper 95th percentile of 
physiologic chemical clearance duration was 148.5 s for infants 
and 114.4  s for children. These children had no fundoplica-
tion, no positive reflux-symptom associations, were not taking 
anti-reflux medications at the time of the study, and had acid 
gastroesophageal reflux indices ≤3% for the children and ≤6% 
for the infants.
Clearance, particularly of non-acid reflux, cannot be picked 
up by pH testing alone. Comparing infants with EA and controls 
with GER, the mean ACT and mean BCT are significantly longer 
in the EA group (39). Correlation between symptoms and clear-
ance time in the EA group showed that the median ACT and BCT 
were significantly shorter in patients without symptoms than in 
those with symptoms. This suggests that it is not the acidity of the 
reflux is that influences symptoms, but the clearance. Findings of 
prolonged bolus and ACT were similarly found in older children 
(40). Studies have shown that esophageal clearance can indicate 
the severity of esophageal dysmotility. In one study, while 79% 
of swallows were accompanied by abnormal motility patterns, 
approximately 60% of swallows showed abnormal bolus transit, 
and 66% of all GER episodes initiated no clearing mechanism 
(41). Furthermore, EA patients have a significantly lower percent-
age of complete bolus transit for liquid and viscous swallows, 
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and their higher bolus index and reflux indices are significantly 
related to increased symptom scores (29).
Correlating Symptoms with Reflux
Three indices are used to quantify the temporal relationship 
between GER and symptoms. Though they have been validated 
in adults, currently there are few studies validating the use in 
children (33, 42, 43).
•	 Symptom index (SI): the number of symptoms associated with 
reflux divided by the total number of symptoms in 24  h. SI 
>50% is considered abnormal.
•	 Symptom sensitivity index (SII): the number of symptoms 
associated with reflux divided by the total number of reflux 
events in 24 h. SII >10% is considered abnormal.
•	 Symptom associated probability (SAP): calculation of statisti-
cal relation between reflux and symptoms using Fisher’s exact 
test. SAP >95% is interpreted as good temporal association 
between GER and the recorded symptom.
The SI and SSI are simple to calculate, with the former being 
used to determine the percentage of symptoms that are associated 
with reflux events and the latter used to determine the percent of 
reflux events associated with symptoms (30). The SI does not take 
into account all reflux episodes and can provide false-positive 
results when the number of reflux episodes is large or the number 
of symptoms is small. The SSI does not take into account the total 
number of symptoms and can result in false positives when the 
number of reflux episodes is small or the number of symptoms 
is small. The SAP takes all parameters into account and is the 
strongest statistical parameter for symptom association analysis. 
The minimal number of symptoms to obtain an accurate and 
reliable SAP is uncertain (27, 44). Positive symptom association, 
which suggests causality between reflux and symptoms, is defined 
when both SI and SSI are positive or when SAP is positive. Further 
limitations to these symptom indices include (44): (1) registra-
tion of symptoms in a timely fashion is dependent on the child 
and/or parent. (2) The time interval of 2 min between a reflux 
event and symptom is the accepted interval, based on consensus, 
to demonstrate a time association. However, this time interval is 
not evidence based and may differ based on symptoms. For some 
symptoms that have a chronic GER relation such as wheezing, 
laryngitis, or bronchial hyperreactivity, temporal symptoms asso-
ciation may not be achieved. Symptoms such as cough, apnea, and 
chest pain likely have a shorter time frame.
pH-multichannel intraluminal impedance monitoring is use-
ful in evaluating and correlating non-acid reflux with symptoms 
in the following patient groups: symptomatic patients on proton 
pump inhibitor (PPI), patients on continuous feeds, patients with 
extraintestinal symptoms, patients with BRUE, and GER symp-
toms with normal pH probe and endoscopy results (22). Since 
many EA patients are already on anti-reflux therapy, may have a 
frequent feeding schedule, or may be on tube feeds, the majority 
of their refluxate is non-acidic and would otherwise be missed by 
conventional pH testing (28). In a study comparing infants with 
EA and controls with GER, reflux events in both groups were 
mainly non-acid (39). Weakly acid reflux has also been shown 
to be responsible for a significant percentage of symptoms in 
EA patients (29). In a separate study comparing EA patients and 
controls with GER, there was no difference in the total retrograde 
bolus movements between the two groups, though the EA group 
had significantly higher non-acid RI (21, 29). In the EA patients, 
28–42% of symptom occurrences were associated with retrograde 
bolus movements. The utility of pH-impedance compared to pH-
metry alone is further elucidated when comparing the SI between 
the two modes. Significantly more EA patients had a positive SI 
when using pH-MII than pH probe alone (42).
pH-impedance is useful in quantifying the proportion of reflux 
reaching up to the proximal esophagus, referred to as “high reflux.” 
EA patients frequently experience extraesophageal symptoms, 
and pH-MII has the unique ability to determine if these symptoms 
correlate with reflux episodes, whether they are acid or non-acid. 
In one study, 39% of the coughs recorded were associated with 
reflux (29). In that study, of the four patients who showed more 
than 50% high-reflux episodes, three had chronic pulmonary 
problems with frequent postprandial coughing. Of these high 
refluxes, 47% were weakly acidic and 53% were acidic. In another 
study, 62% of coughs were associated with reflux in children 
≤1 year old, and 58% of coughs were associated with reflux in 
children >1 year old (39). Cough episodes were more commonly 
seen with acid reflux, though compared to children >1 year old, 
younger children had more frequent cough episodes related to 
non-acid reflux. In a study correlating symptoms in EA to the 
presence of GERD, the most frequent symptoms in children with 
GERD included cough, recurrent bronchitis, and heartburn, 
though this did not reach clinical significance (45).
When patients with EA have non-acid reflux associated with 
complications, particularly pulmonary or stricture related, medi-
cal management with prokinetics is recommended. If this fails, 
fundoplication or transpyloric feeds should be considered. While 
fundoplication can have higher complications in EA patients, it is 
indicated in the following cases: patients with significant extrae-
sophageal symptoms related to GERD including cyanotic spells, 
patients with recurrent anastomotic strictures, and esophagitis 
despite maximal PPI therapy (12).
beneFiTS OF pH-Mii
As discussed above, pH-MII provides multiple benefits over 
pH probe alone, and should be considered, when available, for 
diagnosing and monitoring for GER in EA. It not only quanti-
fies acid and non-acid exposure, but also is more effective in 
correlating symptoms to reflux, and can measure both volume 
and chemical clearance. In a pH-MII study of 700 children with 
GERD symptoms, 45% of the patients with abnormal GER would 
not have been recognized by 24-h pH measurement alone (33). 
In addition, extraintestinal symptoms of GER, which were more 
common in younger children, were more often correlated with 
pH-MII as compared to pH alone.
It should be noted that GERD is often more severe than 
predicted based on the clinically reported symptoms (21, 29). 
Reliance on symptoms is insufficient in determining whether 
acid suppression is needed. Given the high-risk of complications 
from GERD, particularly the high-risk of anastomotic stricture 
in the first year of life, it is recommended that patients stay on 
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empiric therapy with acid suppression for the first year of life. 
They should also undergo monitoring of GER with impedance/
pH and/or endoscopy at the time of antacid discontinuation and 
during long-term follow-up (12).
LiMiTATiOnS OF pH-Mii
One of the limitations of pH-MII in patients with EA is that the 
baseline impedances are 75% lower than control patients (29). 
Because of this, software analysis often does not detect reflux 
events. As a result, manual analysis must be done in addition to 
automated, to prevent underreporting of reflux (12). While there 
is a single large study that has reported age-related normal data 
for reflux indices (32), symptom association statistics are largely 
based on adult data. The time interval between symptoms and 
reflux events is based on consensus, with little evidence on the 
ideal time frame between different types of symptoms. As there 
are no large outcomes, studies on treating weakly acid and non-
acid reflux with anti-reflux surgery, medications that decrease 
transient LES relaxation, or promotility agents, the clinical 
relevance of measuring this type of reflux remains debatable. In 
addition, the analysis of pH-MII requires special training and 
it is time consuming. These tests are also not available to every 
medical practice. pH probe testing is easier to interpret and more 
accessible to providers.
COnCLUSiOn
Because of the increased prevalence and significant morbidity 
associated with GER in EA/TEF patients, diagnosing and moni-
toring for GER is essential. The recommendations are to treat 
all EA patients in the first year of life with PPIs, and to monitor 
for GER thereafter. pH monitoring is recommended to evaluate 
the severity of acid reflux and the symptoms associated with it. 
pH-impedance monitoring provides additional benefits of corre-
lating non-acid reflux and esophageal clearance with symptoms. 
These tools help guide the duration of antacid therapy and the 
need for surgical intervention.
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